Fildena XXX
$ 48,00 – $ 137,00Price range: $ 48,00 through $ 137,00
Finast
$ 78,00 – $ 540,00Price range: $ 78,00 through $ 540,00
Finalo
$ 26,00 – $ 52,00Price range: $ 26,00 through $ 52,00
Finalo is a highly effective oral treatment specifically developed to address male pattern hair loss. Its active ingredient works by reducing the levels of DHT in the scalp, which helps protect hair follicles from shrinking. Regular use of this medication can significantly slow down the thinning process and encourage the regrowth of healthy hair. It is designed for men looking to improve hair density and treat a receding hairline or thinning at the crown. Consistent daily use results in a fuller appearance by maintaining and restoring natural hair growth over time.
Active substance: Finasteride
SKU:
Finalo
Categories: Hair Loss, Men's Health
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Finalo belongs to a class of medications known as Type II 5-alpha reductase inhibitors. It is prescribed under medical supervision for the treatment of male pattern hair loss (androgenetic alopecia) in adult male patients.
In accordance with federal regulations in the United States, this medication is available strictly by prescription (Rx). Proper evaluation by a licensed healthcare professional is required to establish an accurate diagnosis and determine treatment appropriateness before initiating therapy.
| Parameter | Clinical Details |
|---|---|
| Active Ingredient | Finasteride (1 mg) |
| Therapeutic Class | Type II 5-Alpha Reductase Inhibitor |
| Primary Indication | Androgenetic Alopecia (Male Pattern Hair Loss) |
| Route of Administration | Oral |
| Dosing Schedule | 1 mg once daily |
| Prescription Status | Prescription-Only (Rx) |
Medical Overview and Clinical Information
How the Drug Works and What It’s Used For
How the drug works: The primary active component of Finalo is finasteride, a synthetic 4-azasteroid compound that acts as a specific competitive inhibitor of the Type II 5-alpha reductase enzyme. This intracellular enzyme is responsible for converting testosterone into dihydrotestosterone (DHT) within scalp tissue, hair follicles, and the prostate gland. By selectively inhibiting Type II 5-alpha reductase, finasteride suppresses circulating levels of serum DHT by approximately 65% to 70%, and substantially lowers DHT concentrations within the scalp tissue. In individuals genetically predisposed to androgenetic alopecia, DHT causes hair follicle miniaturization. Lowering localized DHT levels helps halt the miniaturization process, encouraging stabilization of scalp hair density and promoting secondary hair growth.
What it’s used for: Finalo is indicated for the treatment of male pattern hair loss (androgenetic alopecia) in adult males, primarily targeting vertex and anterior mid-scalp hair thinning. It is not indicated for the treatment of bitemporal recession alone. This medication is explicitly contraindicated for use in women and pediatric patients. Off-label use of finasteride in females–particularly for female pattern hair loss–carries severe risks of teratogenicity and requires strict medical oversight. Women who are pregnant or planning to become pregnant must avoid contact with this active drug due to potential reproductive toxicity risks to a male fetus.
Dosing Schedule and What Happens in the Body
Dosing schedule: The recommended standard dosage for adult males is one 1 mg tablet taken orally once daily. The tablet should be swallowed whole with fluid and may be administered with or without food. Clinical efficacy studies demonstrate that continuous daily use for three to six months is typically necessary before noticeable hair growth stabilization or improvement occurs. Consistent daily administration is required to maintain therapeutic benefits; discontinuation of treatment results in a gradual reversal of effect, with scalp hair density returning to baseline levels within 9 to 12 months.
What happens in the body (Pharmacokinetics): Following oral administration, finasteride is rapidly absorbed from the gastrointestinal tract. The mean bioavailability of finasteride is approximately 63% relative to an intravenous reference dose, and its oral absorption is not significantly affected by co-administration with food. Peak plasma concentrations (Cmax) are reached approximately 1 to 2 hours after dose intake. In circulating plasma, finasteride is approximately 90% bound to plasma proteins. The drug crosses the blood-brain barrier in small amounts, and trace concentrations have been detected in seminal fluid.
Finasteride undergoes extensive hepatic metabolism, primarily mediated by the cytochrome P450 3A4 (CYP3A4) enzyme system. Two major inactive metabolites are formed following oxidative biotransformation. The mean terminal elimination half-life of finasteride ranges from 5 to 6 hours in healthy adult males under 60 years of age, extending to approximately 8 hours in elderly individuals. Excretion occurs through dual pathways: approximately 57% of an oral dose is eliminated in the feces via biliary excretion, while roughly 39% is excreted in the urine as metabolites.
Adverse Reactions and Important Precautions
Adverse reactions: Finalo is generally well tolerated, but adverse effects may occur in a subset of patients. Clinical trial data indicate that a small percentage of men experience reproductive side effects during therapy. Reported adverse reactions include decreased libido, erectile dysfunction, and ejaculate disorders (such as reduced ejaculate volume). These events occurred in approximately 1% to 2% of patients during clinical trials. Additional adverse reactions reported in clinical trials or post-marketing surveillance include testicular pain, breast tenderness or enlargement (gynecomastia), hypersensitivity reactions (including cutaneous rash, pruritus, and urticaria), mood alterations, depression, and anxiety.
Important precautions: Patients undergoing screening or monitoring for prostate disorders should note that finasteride therapy reduces serum Prostate-Specific Antigen (PSA) concentrations by approximately 50% in adult men. When interpreting serum PSA measurements in patients taking Finalo, values must be adjusted (typically doubled) to establish an accurate baseline relative to untreated normal ranges. Furthermore, physicians should carefully evaluate patients presenting with mood changes, as persistent depressive symptoms have been reported. Women who are pregnant or of childbearing potential must not handle crushed or broken Finalo tablets due to the risk of transdermal absorption and subsequent developmental harm to a male fetus.
Safety Red Flags and Compatibility
Red flags: Patients must seek immediate medical evaluation if they observe signs of severe systemic allergic reactions, such as angioedema (swelling of the face, lips, tongue, or throat), severe skin eruptions, or difficulty breathing. Immediate consultation with a physician is also indicated if a patient experiences severe changes in mood, persistent clinical depression, suicidal ideation, or localized breast tissue changes (such as lumps, persistent pain, or nipple discharge).
Compatibility with other medicines: Clinical drug interaction studies have not identified clinically significant interactions between finasteride and other common pharmaceutical agents. Specific pharmacokinetic studies evaluated co-administration with antipyrine, digoxin, propranolol, theophylline, and warfarin; no clinically meaningful alterations in pharmacokinetic parameters were observed. Finasteride is metabolized by CYP3A4, but it does not appear to significantly alter the metabolism of other drugs cleared by this enzyme. Concomitant administration of Finalo with systemic 5-alpha reductase inhibitors used for benign prostatic hyperplasia is not recommended.
What to avoid while taking it: There are no direct pharmacokinetic interactions reported between finasteride and moderate alcohol consumption. However, maintaining routine medical evaluations is recommended. Crushing, breaking, or chewing tablets must be strictly avoided to prevent unintentional exposure to household contacts, particularly women of childbearing age.
Supplementary Patient Guidance
If You Skip a Dose: If a dose of Finalo is missed, the patient should skip the missed tablet and resume the standard schedule by taking the next scheduled dose at the regular time. The patient must not take a double dose to compensate for a missed tablet, as this does not enhance therapeutic efficacy and may increase the likelihood of adverse effects.
Storage and Expiration: Store Finalo at controlled room temperature between 20°C and 25°C (68°F to 77°F), with permitted excursions between 15°C and 30°C (59°F to 86°F). Store the medication in its original container to protect the tablets from moisture and direct light exposure. Keep out of reach of children. Properly discard any medication that is past its stated expiration date or no longer needed.
Common Questions:
How long does it take to evaluate whether Finalo is effective?
Therapeutic response to 5-alpha reductase inhibition develops gradually. Daily clinical use for 3 to 6 months is usually necessary to evaluate initial stabilization of hair loss. Maximum benefit is typically observed after 12 months of continuous daily therapy.
What happens if treatment with Finalo is discontinued?
Discontinuing the medication results in the restoration of baseline 5-alpha reductase activity and scalp DHT levels. Over the course of 9 to 12 months following cessation, hair density benefits achieved during treatment will gradually reverse.
Can Finalo be taken with food?
Yes. Bioavailability studies demonstrate that the rate and extent of finasteride absorption are not meaningfully altered by food intake, allowing the medication to be taken either with or without meals.
Does Finalo interact with prostate cancer screening tests?
Yes. Finasteride lowers baseline serum PSA levels by approximately 50%. Patients must inform their prescribing provider and clinical laboratory personnel that they are taking Finalo prior to undergoing PSA screening.
Is Finalo safe for use in female pattern hair loss?
Finalo is not FDA-approved for female pattern hair loss. Its use in females is contraindicated, particularly in women who are or may become pregnant, due to significant risks of teratogenic malformations in male fetuses.
This text is for informational purposes only and does not constitute individual medical advice. In accordance with FDA regulatory guidelines, decisions regarding drug prescription, dosage, and monitoring must be performed by a qualified healthcare professional.
Additional information
| Dosage |
1 mg |
|---|---|
| Package |
30 pills ,60 pills ,90 pills |
| Ενεργός Ουσία |
Related products
Adgain
$ 32,00 – $ 78,00Price range: $ 32,00 through $ 78,00
More Details
This product has multiple variants. The options may be chosen on the product page
Dutas
$ 57,00 – $ 464,00Price range: $ 57,00 through $ 464,00
Active substance: Dutasteride
More Details
This product has multiple variants. The options may be chosen on the product page
Keraglo Men
$ 23,00 – $ 83,00Price range: $ 23,00 through $ 83,00
More Details
This product has multiple variants. The options may be chosen on the product page
Mintop Solution
$ 9,00 – $ 213,00Price range: $ 9,00 through $ 213,00
Active substance: Minoxidil
More Details
This product has multiple variants. The options may be chosen on the product page
Morr F
$ 100,00 – $ 307,00Price range: $ 100,00 through $ 307,00
Active substance: Finasteride, Minoxidil
More Details
This product has multiple variants. The options may be chosen on the product page
Perfectil
$ 75,00 – $ 135,00Price range: $ 75,00 through $ 135,00
More Details
This product has multiple variants. The options may be chosen on the product page
Rogaine 2
$ 51,00 – $ 217,00Price range: $ 51,00 through $ 217,00
Active substance: Minoxidil
More Details
This product has multiple variants. The options may be chosen on the product page
Rogaine 5
$ 47,00 – $ 315,00Price range: $ 47,00 through $ 315,00
Active substance: Minoxidil
More Details
This product has multiple variants. The options may be chosen on the product page
